Philip Morris International Focuses on U.S. Growth Through ZYN Expansion

Philip Morris International (PMI) is prioritizing U.S. market expansion to sustain long-term growth, relying on its smoke-free portfolio to drive earnings. The company maintains an "attainable algorithm" for medium-term earnings-per-share growth in the low double-digit to low teens range, supported by six consecutive years of total volume growth.

"We are in this unique situations that unlike companies are going from the U.S. and are trying to search for a growth in some other markets outside. In a case of a PMI, we have this particular case that we have a growth on international, but unaddressed till today opportunity to large extent is the U.S.," said Jacek Olczak, CEO of Philip Morris International, during the Barclays Global Consumer Staples Conference.

Expanding the U.S. Smoke-Free Portfolio

The company is scaling its ZYN nicotine pouch brand in the United States. Recent moves include the launch of new "Ultra" variants, offering 9 mg and 11 mg nicotine strengths, alongside a 1.5 mg lower-strength option. The brand is also transitioning to 20-count packaging to standardize the consumer experience and optimize supply chain efficiency.

Beyond nicotine pouches, the company is waiting on FDA Premarket Tobacco Product Application (PMTA) authorization for the ILUMA version of its IQOS heated tobacco system. Securing this approval is a central pillar of the company's strategy to capture a larger share of the U.S. tobacco market.

Financial Outlook and Currency Headwinds

PMI is navigating the global macroeconomic environment. It expects a favorable currency impact of approximately $0.24 per share for the full year 2026, according to a transcript of the Barclays conference.

Why the U.S. Shift Matters

For investors and industry observers, the pivot toward the U.S. represents a departure from the traditional tobacco model, which has historically focused on international markets for volume. By leveraging its existing smoke-free infrastructure to enter the U.S., PMI is attempting to capitalize on a market that offers scale for non-combustible products. The success of this transition depends on the regulatory approval process for products like ILUMA and the sustained consumer adoption of its expanded ZYN lineup.